Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹1.01 Cr₹-15 Cr₹-44 Cr₹130 Cr₹0.78 Cr

What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH is ₹1.01 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹1.01 Cr
Mar2024₹-15 Cr
Mar2023₹-44 Cr
Mar2022₹130 Cr
Mar2021₹0.78 Cr

How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹1.01 Cr
Positive
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹-44 Cr
Negative
Mar2022 ₹130 Cr
16,663.92
Mar2021 ₹0.78 Cr -

Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,631.4 Cr 1.9% -10.2% -17.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,725.0 Cr -3.2% 10.5% 9.3% Stock Analytics
DIVIS LABORATORIES ₹182,775.0 Cr 0.8% 9.5% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,764.0 Cr 2% 9.9% 35.4% Stock Analytics
CIPLA ₹113,007.0 Cr -1.9% 13.3% -6% Stock Analytics
DR REDDYS LABORATORIES ₹109,098.0 Cr -1.8% 7.4% 8.2% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

1.9%

-10.2%

-17.2%

SENSEX

0.2%

-4.9%

-8.4%


You may also like the below Video Courses